Food and Microbiome Longitudinal Investigation

Food and Microbiome Longitudinal Investigation (FAMiLI) is an ongoing prospective cohort study that has enrolled a diverse cohort in the United States to study how the human microbiome and diet are related to various chronic diseases, including cancer, heart disease, and diabetes. Eligible participants are at least 40 years old, not pregnant, and not using long-term antibiotics. As of January 2023, the study has recruited over 9,500 participants of varying racial/ethnic backgrounds (White, Asian, Black, and Hispanic), and nativity (U.S.-born and foreign-born). Participants provide oral and stool samples, and complete demographic and dietary questionnaires. Long-term follow-up will examine cancer and other disease outcomes.

食品与微生物组纵向研究（FAMiLI）是一项持续进行的队列研究，旨在探讨人类微生物组与饮食如何关联多种慢性疾病，包括癌症、心脏病和糖尿病。符合资格的参与者需年满40岁，非孕妇，且未长期使用抗生素。截至2023年1月，该研究已招募超过9,500名具有不同种族/民族背景（白人、亚洲人、黑人及西班牙裔）和出生地（美国出生及外籍出生）的参与者。参与者需提供口腔和粪便样本，并完成人口统计学和饮食问卷调查。长期追踪将研究癌症及其他疾病的结果。